Endocrine treatment of advanced breast cancer: focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Basingstoke
Nature Publ. Group
2004
|
| Schriftenreihe: | British journal of cancer
90, Suppl. 1 |
| Beschreibung: | 18 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV018160520 | ||
| 003 | DE-604 | ||
| 005 | 20171128 | ||
| 007 | t | ||
| 008 | 040416s2004 d||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)66543396 | ||
| 035 | |a (DE-599)BVBBV018160520 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-19 |a DE-20 | ||
| 245 | 1 | 0 | |a Endocrine treatment of advanced breast cancer |b focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects |c guest ed.: A. Howell |
| 264 | 1 | |a Basingstoke |b Nature Publ. Group |c 2004 | |
| 300 | |a 18 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a British journal of cancer |v 90, Suppl. 1 | |
| 700 | 1 | |a Howell, Anthony |e Sonstige |0 (DE-588)17368422X |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-010931309 | ||
Datensatz im Suchindex
| _version_ | 1804130749867098112 |
|---|---|
| any_adam_object | |
| author_GND | (DE-588)17368422X |
| building | Verbundindex |
| bvnumber | BV018160520 |
| ctrlnum | (OCoLC)66543396 (DE-599)BVBBV018160520 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00854nam a2200253 cb4500</leader><controlfield tag="001">BV018160520</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20171128 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">040416s2004 d||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)66543396</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV018160520</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Endocrine treatment of advanced breast cancer</subfield><subfield code="b">focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects</subfield><subfield code="c">guest ed.: A. Howell</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basingstoke</subfield><subfield code="b">Nature Publ. Group</subfield><subfield code="c">2004</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">18 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">British journal of cancer</subfield><subfield code="v">90, Suppl. 1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Howell, Anthony</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)17368422X</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-010931309</subfield></datafield></record></collection> |
| id | DE-604.BV018160520 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:25:59Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-010931309 |
| oclc_num | 66543396 |
| open_access_boolean | |
| owner | DE-19 DE-BY-UBM DE-20 |
| owner_facet | DE-19 DE-BY-UBM DE-20 |
| physical | 18 S. graph. Darst. |
| publishDate | 2004 |
| publishDateSearch | 2004 |
| publishDateSort | 2004 |
| publisher | Nature Publ. Group |
| record_format | marc |
| series2 | British journal of cancer |
| spelling | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects guest ed.: A. Howell Basingstoke Nature Publ. Group 2004 18 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier British journal of cancer 90, Suppl. 1 Howell, Anthony Sonstige (DE-588)17368422X oth |
| spellingShingle | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects |
| title | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects |
| title_auth | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects |
| title_exact_search | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects |
| title_full | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects guest ed.: A. Howell |
| title_fullStr | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects guest ed.: A. Howell |
| title_full_unstemmed | Endocrine treatment of advanced breast cancer focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects guest ed.: A. Howell |
| title_short | Endocrine treatment of advanced breast cancer |
| title_sort | endocrine treatment of advanced breast cancer focus on fulvestrant faslodex an oestrogen receptor antagonist with no agonist effects |
| title_sub | focus on fulvestrant ("faslodex"), an oestrogen receptor antagonist with no agonist effects |
| work_keys_str_mv | AT howellanthony endocrinetreatmentofadvancedbreastcancerfocusonfulvestrantfaslodexanoestrogenreceptorantagonistwithnoagonisteffects |